Cristina Gázquez

Universidad de Navarra — Spain

Medicine · Health Sciences

14h-index759citations32works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bladder and Urothelial Cancer Treatments(11), Trace Elements in Health(10), Heavy Metal Exposure and Toxicity(4), Peptidase Inhibition and Analysis(4), Sperm and Testicular Function(3)

Publications32 total

High value of 64Cu as a tool to evaluate the restoration of physiological copper excretion after gene therapy in Wilson’s disease
Molecular Therapy — Methods & Clinical Development·2022· 21 citedOpen Access
Maturation of NAA20 Aminoterminal End Is Essential to Assemble NatB N-Terminal Acetyltransferase Complex
Journal of Molecular Biology·2020· 4 cited
FRI-430-Preclinical validation of copper 64 as a translational tool for evaluating the pharmacodynamics of VTX-801 genen therapy in Wilson’s disease
Journal of Hepatology·2019
Liver Expression of a MiniATP7B Gene Results in Long‐Term Restoration of Copper Homeostasis in a Wilson Disease Model in Mice
Hepatology·2019· 51 cited
Brain copper storage after genetic long-term correction in a mouse model of Wilson disease
Neurology Genetics·2018· 21 citedOpen Access
Gene therapy optimization for Wilson’s disease
Journal of Hepatology·2018· 1 cited
Visualization of the therapeutic efficacy of a gene correction approach in Wilson’s disease by laser-ablation inductively coupled mass spectrometry
Journal of Hepatology·2018· 15 cited
NatB-mediated protein N-α-terminal acetylation is a potential therapeutic target in hepatocellular carcinoma
Oncotarget·2017· 32 citedOpen Access
Improvement of gene therapy for Wilson’s disease
Journal of Hepatology·2017
164. Improvement of Gene Therapy for Wilson Disease
Molecular Therapy·2016· 4 citedOpen Access
Long-term metabolic correction of Wilson’s disease in a murine model by gene therapy
Journal of Hepatology·2015· 125 cited
702. Long Term Metabolic Correction of Wilson Disease
Molecular Therapy·2015Open Access
Using microRNA profiling in urine samples to develop a non-invasive test for bladder cancer
International Journal of Cancer·2013· 108 cited
236 Using microRNA profiling in urine samples to develop a non-invasive test for bladder cancer
European Urology Supplements·2013· 15 cited
Biomarcadores de estadiaje molecular y de respuesta terapéutica en pacientes con cáncer de vejiga músculo invasivo
Dialnet (Universidad de la Rioja)·2013
N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB
Proceedings of the National Academy of Sciences·2012· 9 citedOpen Access
Biomarkers vs conventional histological analysis to detect lymph node micrometastases in bladder cancer: a real improvement?
British Journal of Urology·2012· 23 cited
Utility of Urothelial mRNA Markers in Blood for Staging and Monitoring Bladder Cancer
Urology·2011· 22 cited
866 DIFFERENTIAL MIRNA EXPRESSION PROFILES IN URINES FROM BLADDER CANCER PATIENTS
The Journal of Urology·2011
358 PREDICTING THE RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH UROTHELIAL CELL CARCINOMA BY MIRNA EXPRESSION PROFILE
The Journal of Urology·2011
page 1 of 2Next →

Frequent Co-authors

Lourdes Mengual(12), Antonio Alcaraz(12), Daniel Moreno(10), Gloria González‐Aseguinolaza(10), María J. Ribal(10), Rubén Hernández-Alcoceba(8), Oihana Murillo(7), Jesús Prìeto(6), Í. Navarro-Blasco(5), Mercedes Ingelmo‐Torres(5), Mercedes Marín‐Aguilera(5), Pedro L. Fernández(5), Rafael Oliva(4), Marta Lasa(4), Rafael Aldabe(4), Juan José Lozano(3), José Luís Ballescà(3), Miren Barberia(3), Verónica Ferrer(3), Bernard Bénichou(3)